Atlas Trials

Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

Clinical trial NCT01220297 · TERMINATED

Trial details

NCT number
NCT01220297
Sponsor
Stanford University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hematologic DiseasesAcute-graft-versus-host DiseaseLeukemiaNon-Hodgkin Lymphoma (NHL)Hodgkin Lymphoma
Start date
2006-08-01
Primary completion
2010-08-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.